These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3348466)

  • 1. The organic mental disorders subsection of DSM-III-R.
    Bedi A
    Am J Psychiatry; 1988 Apr; 145(4):534-5. PubMed ID: 3348466
    [No Abstract]   [Full Text] [Related]  

  • 2. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I).
    Skre I; Onstad S; Torgersen S; Kringlen E
    Acta Psychiatr Scand; 1991 Aug; 84(2):167-73. PubMed ID: 1950612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year incidence and predictors of first-onset of DSM-IV mood, anxiety, and substance use disorders in older adults: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Chou KL; Mackenzie CS; Liang K; Sareen J
    J Clin Psychiatry; 2011 Feb; 72(2):144-55. PubMed ID: 21382305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis in MH settings: heed signs of substance abuse.
    Sauerland RM
    Behav Healthc Tomorrow; 2003 Oct; 12(5):36-8. PubMed ID: 14564969
    [No Abstract]   [Full Text] [Related]  

  • 5. Organic affective illness associated with lead intoxication.
    Schottenfeld RS; Cullen MR
    Am J Psychiatry; 1984 Nov; 141(11):1423-6. PubMed ID: 6496787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-observer reliability of DSM-5 substance use disorders.
    Denis CM; Gelernter J; Hart AB; Kranzler HR
    Drug Alcohol Depend; 2015 Aug; 153():229-35. PubMed ID: 26048641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatry. Experts map the terrain of mood disorders.
    Holden C
    Science; 2010 Feb; 327(5969):1068. PubMed ID: 20185697
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between social isolation and DSM-IV mood, anxiety, and substance use disorders: wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Chou KL; Liang K; Sareen J
    J Clin Psychiatry; 2011 Nov; 72(11):1468-76. PubMed ID: 21295001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the diagnostic criteria for psychosomatic research in substance use disorder patients.
    Tossani E; Ricci Garotti MG; Cosci F
    Psychother Psychosom; 2013; 82(3):195-6. PubMed ID: 23549064
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.
    Janca A; Robins LN; Bucholz KK; Early TS; Shayka JJ
    Acta Psychiatr Scand; 1992 Jun; 85(6):440-3. PubMed ID: 1642126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSM-5 proposals for mood disorders: a cost-benefit analysis.
    First MB
    Curr Opin Psychiatry; 2011 Jan; 24(1):1-9. PubMed ID: 21042219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of therapeutic advances in widening the nosologic boundaries of affective disorders: clinical and research implications.
    Akiskal HS; Cassano GB
    Pharmacopsychiatria; 1983 Jul; 16(4):111-8. PubMed ID: 6634936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family study of anxiety disorders: familial transmission and relationship to mood disorder and psychoactive substance use disorder.
    Skre I; Onstad S; Edvardsen J; Torgersen S; Kringlen E
    Acta Psychiatr Scand; 1994 Nov; 90(5):366-74. PubMed ID: 7872042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.
    Fatseas M; Serre F; Swendsen J; Auriacombe M
    Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam dependence in seven patients.
    Juergens SM; Morse RM
    Am J Psychiatry; 1988 May; 145(5):625-7. PubMed ID: 3258735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSM-III as a research tool.
    Treece C
    Am J Psychiatry; 1982 May; 139(5):577-83. PubMed ID: 7072841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders.
    Brown TA; Di Nardo PA; Lehman CL; Campbell LA
    J Abnorm Psychol; 2001 Feb; 110(1):49-58. PubMed ID: 11261399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of Internet-based screening for anxiety disorders: a pilot study.
    Van Ameringen M; Mancini C; Simpson W; Patterson B
    Depress Anxiety; 2010 Nov; 27(11):1006-10. PubMed ID: 20721902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.